Skip to contentSkip to footer
Investor Relations

Investor Relations

At Alere, we aim to improve clinical outcomes, reduce healthcare costs and deliver earnings growth to our investors. We strive to build open relationships with our shareholders and prospective investors, and we manage these relationships in accordance with company policies and relevant securities law.

A global leader in rapid point-of-care diagnostics, our products, as well as our new product development efforts, focus on infectious disease, cardiometabolic disease and toxicology. Being a leading developer of innovative diagnostic and monitoring devices allows us to improve care and lower healthcare costs for both providers and patients.


Annual Meetings & Reports

Annual Meetings and Reports

Read More


SEC Filings & Financials

Securities and Exchange Commission Filings

Read More


Earnings Releases

We interact with our shareholders and prospective investors through multiple channels.

Read More


Corporate Governance

Alere has a firmly established policy of conducting our affairs in compliance with the letter and spirit of the law and adhering to the principles of business ethics.

Read More


Presentations & Events

Explore how Alere is advancing the world of health diagnostics at the point-of-care.

Read More


Contact Information

We appreciate your interest in Alere. Please use this contact information for help with your inquiry.

Read More


Investor Relations

Click below to contact us directly regarding opportunities.